发明名称 Treating critically ill patients with intravenous ibuprofen
摘要 Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.
申请公布号 US8871810(B2) 申请公布日期 2014.10.28
申请号 US200912646499 申请日期 2009.12.23
申请人 Cumberland Pharmaceuticals Inc. 发明人 Pavliv Leo;Rock Amy Dix
分类号 A01N37/10;A61K31/19;A61K31/197;A61K31/192 主分类号 A01N37/10
代理机构 Davidson, Davidson & Kappel, LLC 代理人 Davidson, Davidson & Kappel, LLC
主权项 1. A method of treating pain in critically ill patients in need thereof, comprising administering to critically ill patients an intravenous ibuprofen pharmaceutical composition in a dose of about 800 mg and providing a mean Cmax of about 60 μg/ml to treat pain in said patients, wherein the critically ill patients are not suffering from inflammation and are receiving at least one treatment selected from vasopressor support and mechanical ventilation.
地址 Nashville TN US